-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Infinity Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
- Infinity Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2023 was -$10.1M, a 15.8% increase year-over-year.
- Infinity Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2023 was -$42M, a 9.92% increase year-over-year.
- Infinity Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$44.8M, a 0.53% increase from 2021.
- Infinity Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$45.1M, a 17.1% decline from 2020.
- Infinity Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$38.5M, a 15.7% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)